⌘K

Home/Filings/4/0001144204-17-031973

4//SEC Filing

CASI Pharmaceuticals, Inc. 4

Accession 0001144204-17-031973

CIK 0000895051operating

View on SEC.gov Company Profile

Filed

Jun 8, 8:00 PM ET

Accepted

Jun 9, 5:02 PM ET

Size

5.4 KB

Accession

0001144204-17-031973

Insider Transaction Report

Form 4

Period: 2017-06-08

CASI Pharmaceuticals, Inc.CASI

CAPITELLI SARA B

VP, Finance and PAO

Transactions

Award
Stock Options (Right to Buy)
2017-06-08+50,000→ 50,000 total
Exercise: $1.01Exp: 2027-06-08→ Common Stock (50,000 underlying)

Footnotes (1)

[F1]The stock options vest as follows: 25% on the date of grant, and the remainder ratably over three years on a monthly basis.

Documents

1 file

4
v468779_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

CASI Pharmaceuticals, Inc.

CIK 0000895051

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000895051

Filing Metadata

Form type: 4
Filed: Jun 8, 8:00 PM ET
Accepted: Jun 9, 5:02 PM ET
Size: 5.4 KB

View on SEC.gov